Daily Pill Shows Promise in Slowing Type 1 Diabetes Progression
The BANDIT trial in Australia explores baricitinib's potential in delaying Type 1 diabetes onset. The cessation of baricitinib reveals a loss of its benefits, prompting further exploration in earlier disease stages.